CytoMed Therapeutics Financial Statements 2022-2025 | GDTC

Fifteen years of historical annual and quarterly income statements for CytoMed Therapeutics (GDTC).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM202420232022
$0.00$0.05$0$0
$0.00$0$0$0
$0.00$0.05$0$0
$0.00$1.40$1.21$1.14
$0.00$0$0$0
$0.00$0.33$-0.11$-0.63
$0.00$0$0$0
$0.00$-1.11$-1.39$-1.85
$0.00$-0.74$-1.74$-0.49
$0.00$-1.85$-3.13$-2.34
$0.00$0$0.00$0.00
$0.00$-1.85$-3.13$-2.34
$0.00$0$0$0
$0.00$-1.85$-3.13$-2.34
$0.00$0$0$0
$0.00$-1.84$-3.13$-2.34
$0.00$-0.87$-1.10$-1.55
$0.00$-1.11$-1.39$-1.85
$0.00$-0.16$-0.29$-0.30
$0.00$-0.16$-0.29$-0.30

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-12-312024-06-302023-12-312023-06-302022-12-31
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0.00$0.00$0.00$0.00$0.00